-
The youngest tots already are supposed to get three extra-small doses of the original vaccine as their primary series. Pfizer says that if the FDA agrees, the updated vaccine would be used for the third shot.
-
While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.
-
The drugmaker says it expects many people will continue receiving doses for free. However, commercial pricing for adult doses could start early next year, depending on when the U.S. government phases out its vaccine program.
-
Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older -- two primary shots plus a booster.
-
Moderna CEO Stephane Bancel said in a prepared statement that the vaccine developer pioneered that technology and invested billions of dollars in creating it.
-
The research is likely to renew questions about the Biden administration's use of the pill, which has become a go-to treatment for COVID-19 due to its at-home convenience.
-
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
-
The only Lyme vaccine for humans was pulled off the U.S. market in 2002 from lack of demand, leaving people to rely on bug spray and tick checks.
-
Paxlovid has been shown to curb the worst effects of COVID-19 but it has to be started within five days of symptoms. Previously, only doctors could prescribe it.
-
The drugmaker has the best-selling vaccine to prevent COVID and the most effective drug to treat it. Its success and might have overshadowed the government’s COVID-fighting strategy.